[Prognostic significance and molecular targeting therapy of hepatocyte growth factor (HGF) in multiple myeloma].
Hattori
Yutaka
Y
D000818:Animals; D014408:Biomarkers, Tumor / Q000097:blood*; D015316:Genetic Therapy / Q000379:methods*; D017228:Hepatocyte Growth Factor / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000098:blood supply / Q000175:diagnosis* / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D011379:Prognosis; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors* / Q000502:physiology; D015398:Signal Transduction
D014408:Biomarkers, Tumor; C066855:HGF protein, human; D017228:Hepatocyte Growth Factor; D019859:Proto-Oncogene Proteins c-met